ALSO NOTED: FDA blesses St. Jude heart valve; China Aoxing to sell narcotic for cancer pain;

> St. Jude Medical got the FDA's OK for a heart valve implant designed to protect against calcification. Report

> China Aoxing Pharmaceutical got its government's go-ahead to make and market Tilidine, a narcotic, to alleviate a shortage of meds for cancer pain. Report

> Beijing Med-Pharm has inked a deal to market and distribute Enablex, a Novartis drug for overactive bladder, in China. Report

> The leukemia drug dexamethasone causes extreme fatigue and sleeplessness in some children, according to a new study published in the online journal Cancer. Report

And Finally... Here's how to better predict liver toxicity: Use a teeny-tiny colony of living cells. Report

Suggested Articles

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.

Hengrui's Sun Piaoyang is stepping down as chairman, but he'll retain control of the pharma major he's headed for 30 years—and made a fortune…

Astellas tapped Adaptimmune to develop T-cell therapies. Ireland hit Takeda with an unexpected Shire tax bill. PD-1 med Tyvyt hit its goal in NSCLC.